Table 4b).
Response | Steroid monotherapy (n=12) |
Mycophenolate mofetil (n=24) |
Eculizumab (n=7) |
Calcineurin inhibitors (n=7) |
Rituximab (n=2) |
---|---|---|---|---|---|
Median Duration (range) | 2.5months(0.2–80.1) | 9.6 months (Range; 1–96.2) | 8.5 months (range: 1.6–26.7) | 17.4months (range: 3.1–50.9) | 0.75 months (0.5–1.0) |
CR | 2 | 1 | 2 | 0 | 0 |
PR | 3 | 2 | 1 | 1 | 1 |
Responder | 1 | 0 | 1 | 0 | 0 |
NR | 4 | 15 (of which 3 reached ESRD) | 3 (of which 2 reached ESRD) | 6 (of which 1 reached ESRD) | 0 |
SD | 1 | 4 | 0 | 0 | 1 |
Lost to follow-up | 1 | 2 | 0 | 0 | 0 |
Abbreviations: CR, complete response; PR, partial response; NR, no response; SD, stable disease.